TRAW

TRAWS PHARMA INC

TRAW·68232V884·US·Common Stock·Healthcare - Biotechnology-Activist

TRAW (TRAWS PHARMA INC) is held by 21 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($615,609), VANGUARD CAPITAL MANAGEMENT LLC ($278,231), JANE STREET GROUP, LLC ($182,158). Net institutional sentiment: Mixed.

21
Holders
(1 Elite)
$1.4M
Total Value
65% (20)
Consensus
13 buying - 7 selling
13F: Insider & Congress: Updated regularly
TRAW

Smart Money Verdict

View all
Loading verdict
Held by 21 funds
1 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistSMSquadron Master Fund LP0.0%Aug 14, 2026
ActivistSISirenia Capital Management LP9.9%Aug 14, 2026
ActivistIKIkarian Capital, LLC9.5%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
730,000$615,6090.0%-64.27%
0
Increased
330,049(+498.0%)$278,2310.0%-38.39%
26
Increased
216,006(+916.9%)$182,1580.0%-34.65%
25
New
164,376$138,6180.0%-28.45%
31
Increased
111,365(+44.4%)$93,9150.0%-77.49%
20
Increased
54,511(+71.4%)$45,9530.0%-54.21%
21
New
37,454$31,5850.0%-28.45%
30
Unchanged
25,802$21,7590.0%-44.86%
0
New
18,092$15,2570.0%-28.45%
25
Decreased
9,941(-0.1%)$8,3830.0%-92.86%
0
New
4,676$3,9430.0%-28.45%
22
Decreased
3,451(-14.8%)$2,9090.0%-44.93%
0
New
1,947$1,6420.0%-28.45%
17
New
500$4140.0%-28.45%
17
Decreased
468(-87.5%)$3950.0%-63.58%
0
Unchanged
262$2210.0%-63.58%
0
New
91,220$760.0%-28.45%
15
New
12,579$110.0%-28.45%
15
Decreased
2(-91.3%)$20.0%-64.96%
0
New
2$20.0%-28.45%
17

Showing 1-20 of 24

1 / 2
TRAWTRAWTRAWS PHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used